These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2084728)

  • 41. Platelet MAO activity in geriatric patients with depression and dementia.
    Alexopoulos GS; Young RC; Lieberman KW; Shamoian CA
    Am J Psychiatry; 1987 Nov; 144(11):1480-3. PubMed ID: 3674232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
    Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
    Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder.
    Bowden CL; Deutsch CK; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1988 Mar; 27(2):171-4. PubMed ID: 3360718
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of depression in the elderly.
    Williams GO
    Prim Care; 1989 Jun; 16(2):451-74. PubMed ID: 2664841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Monoaminergic activity acts on the visual evoked potentials].
    Magos T
    Neuropsychopharmacol Hung; 2004 Oct; 6(3):144-52. PubMed ID: 15816305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression.
    Fähndrich E; Müller-Oerlinghausen B; Coper H
    Int Pharmacopsychiatry; 1982; 17(1):8-17. PubMed ID: 6979526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression.
    Puzynski S; Bidzinski A; Mrozek S; Zaluska M
    Acta Psychiatr Scand; 1983 Feb; 67(2):96-100. PubMed ID: 6846043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
    Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet MAO activity and age at onset of depression in elderly depressed women.
    Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
    Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
    Sullivan JL; Dackis C; Stanfield C
    Am J Psychiatry; 1977 Feb; 134(2):188-90. PubMed ID: 835743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical differences in children with conduct disorder socialized and undersocialized.
    Rogeness GA; Hernandez JM; Macedo CA; Mitchell EL
    Am J Psychiatry; 1982 Mar; 139(3):307-11. PubMed ID: 7058944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatment.
    Moriearty PL; Herrick C; Shafey M; Bornstein P; Becker RE
    Biol Psychiatry; 1987 Sep; 22(9):1155-8. PubMed ID: 3651533
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.
    Biederman J; Rivinus TM; Herzog DB; Ferber RA; Harper GP; Orsulak PJ; Harmatz JS; Schildkraut JJ
    Am J Psychiatry; 1984 Oct; 141(10):1244-7. PubMed ID: 6486260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism. Correlations with MMPI.
    Winter H; Herschel M; Propping P; Friedl W; Vogel F
    Psychopharmacology (Berl); 1978 Apr; 57(1):63-9. PubMed ID: 96471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship of platelet MAO activity to characteristics of major depressive illness.
    Georgotas A; McCue RE; Friedman E; Hapworth WE; Kim OM; Cooper TB; Chang I; Stokes PE
    Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral markers of catecholamine metabolism among workers occupationally exposed to manganese (Mn).
    Smargiassi A; Mergler D; Bergamaschi E; Vettori MV; Lucchini R; Apostoli P
    Toxicol Lett; 1995 May; 77(1-3):329-33. PubMed ID: 7618158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.